Madrigal Pharmaceuticals, Inc. (MDGL)
477.60
+14.18
(+3.06%)
USD |
NASDAQ |
Feb 06, 16:00
477.25
-0.35
(-0.07%)
After-Hours: 20:00
Madrigal Pharmaceuticals EPS Diluted (Quarterly) : -5.079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Eli Lilly & Co. | 7.390 |
| Crinetics Pharmaceuticals, Inc. | -1.381 |
| Insmed, Inc. | -1.747 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -114.19M |
| Revenue (Quarterly) | 287.27M |
| Total Expenses (Quarterly) | 401.46M |
| Enterprise Value | 10.08B |
| Gross Profit Margin (Quarterly) | 93.57% |
| Profit Margin (Quarterly) | -39.75% |
| Earnings Yield | -2.72% |
| Normalized Earnings Yield | -2.705 |